Loading...
Loading...
BOSTON, MA · CIK 0001346824
New positions
21
Added to
6
Trimmed
13
Exited
13
RA CAPITAL MANAGEMENT, L.P. (BOSTON, MA) reported a portfolio value of $9.97B across 92 positions in their Q3 2026 SEC 13F filing (period ending 2026-09-30). The top 10 positions account for 61.3% of the portfolio.
Top 30 holdings by portfolio weight. Block width = holding percentage. Green = new/increased, red = reduced, gray = unchanged.
| # | Stock | Value↓ | Weight | Change |
|---|---|---|---|---|
| 1 | ASCENDIS PHARMA A/S | $2.34B | 23.50% | - |
| 2 | PBLSPARABILIS MEDICINES INC | $942.16M | 9.45% | +0.8% |
| 3 | PCVXVAXCYTE INC | $652.90M | 6.55% | - |
| 4 | RYTMRHYTHM PHARMACEUTICALS INC | $634.78M | 6.37% | - |
| 5 | EWTXEDGEWISE THERAPEUTICS INC | $340.74M | 3.42% | - |
| 6 | TYRATYRA BIOSCIENCES INC | $266.78M | 2.68% | - |
| 7 | FRNMFREENOME INC | $242.03M | 2.43% | New |
| 8 | COAGHEMAB THERAPEUTICS HOLDINGS | $240.82M | 2.42% | - |
| 9 | NAMSNEWAMSTERDAM PHARMA CO NV | $232.26M | 2.33% | - |
| 10 | SEPNSEPTERNA INC | $215.33M | 2.16% | -21.3% |
| Stock | Value | Shares |
|---|---|---|
| FRNMFREENOME INC | $242.03M | 15,367,270 |
| AMLXAMYLYX PHARMACEUTICALS INC | $124.53M | 4,279,341 |
| WVEWAVE LIFE SCIENCES INC | $99.81M | 26,975,505 |
| LTGOLATIGO BIOTHERAPEUTICS INC | $88.56M | 5,302,933 |
| OBXOBSIDIAN THERAPEUTICS INC | $81.79M | 5,957,103 |
| DAMORA THERAPEUTICS INC | $51.07M | 2,399,702 |
| DBVTDBV TECHNOLOGIES SA-SPON ADR | $43.01M | 3,657,644 |
| AGENAGENUS INC | $40.93M | 4,122,000 |
| SCTXSCRIBE THERAPEUTICS INC | $33.17M | 1,802,178 |
| KRSAKORSANA BIOSCIENCES INC | $28.57M | 892,743 |
One weekly email with notable insider buys, sells and congressional disclosures. Unsubscribe anytime.